Wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Kick off WI

Total questions: 22

Worksheet time: 4mins

Name
Class
Date
1.

What is the prediabetes prevalence that we promote according to data from the United States?

a)

35%

b)

33%

c)

40%

2.

Are patients with diabetes twice as likely to develop hypertension?

a)

YES

b)

NO

3.

What is the HbA1c range of prediabetes?

a)

5.7% - 6.0%

b)

5.2% - 6.4%

c)

5.7% - 6.4%

4.

How many diabetes risk factors do we promote?

a)

10

b)

11

c)

12

5.

What % of adults over 18 years of age were overweight in the world in 2016?

a)

37%

b)

39%

c)

26%

6.

What is the worldwide prevalence of Metabolic Syndrome?

a)

37%

b)

39%

c)

26%

7.

Which of the following treatment guidelines has an algorithm for prediabetes?

a)

ALAD

b)

ADA

c)

AACE

8.

Is the statement that 43% of prediabetics will develop diabetes at 6 years of age and up to 80% at 20 years of age correct?

a)

YES

b)

NO

9.

What % of delayed diabetes development showed metformin plus lifestyle changes in the DPP study at 2.8 years?

a)

-37%

b)

-31%

c)

-30%

10.

What is the optimal dose recommended of metformin for the treatment of prediabetes?

a)

1000mg/day

b)

2000mg/day

c)

1500mg/day

11.

How many questions for men does our prediabetes.la risk test have?

a)

6

b)

7

c)

8

12.

What are the advantages of stepped versus combined therapy for type 2 diabetes?

a)

Individualization of therapy

b)

Appropriate for patients who are close to target

c)

Minimization of adverse events and costs

d)

All of the above

13.

What are the profiles of diabetic patients where we have more opportunities in first line and monotherapy according to the ADA guidelines?

a)

weight and cost

b)

Heart failure

c)

Weight, Cost and Risk of hypoglycemia

14.

According to the ADA guidelines, is GLP-1 recommended in diabetic patients with heart failure?

a)

YES

b)

NO

15.

What patient profiles for Glisulin can we explore with Cardiology?

a)

Patient with moderate CV risk, Metabolic Syndrome

b)

Metabolic syndrome

c)

ASCVD, Patient with moderate CV risk, Metabolic Syndrome

d)

ASCVD, Heart Failure, Patient with moderate CV risk, Metabolic Syndrome

e)

Patient with moderate CV risk

16.

Patients with diabetes and established CV disease with target organ damage or greater or equal than 3 major risk factors

a)

Very high CV risk

b)

High CV risk

c)

Moderate CV risk

17.

Which of these is NOT a CV risk factor according to the ESC?

a)

Smoke

b)

Dyslipidemia

c)

Age

d)

proteinuria

18.

What was the reduction in mortality all-cause metformin in the UKPDS study?

a)

-39%

b)

-36%

c)

-42%

19.

What was the reduction in cerebrovascular disease by metformin in the UKPDS study?

a)

-39%

b)

-36%

c)

-41%

20.

According to the AACE guidelines, is metformin still recommended as 1st-line treatment for all patients diagnosed with diabetes?

a)

YES

b)

NO

21.

What is the fasting glucose range for type 2 diabetes?

a)

Greater than 125 mg/dL

b)

Greater than 100 mg/dL

c)

Greater than 145 mg/dL

22.

Significant reduction in diarrhea with Glucophage XR of:

a)

-50%

b)

-75%

c)

-85%